We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ATXI

Price
0.25
Stock movement up
+- (%)
Company name
Avenue Therapeutics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
513.68K
Ent value
-1.11M
Price/Sales
-
Price/Book
0.31
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-50.07%
1 year return
-97.73%
3 year return
-92.21%
5 year return
-87.88%
10 year return
-
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ATXI does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book0.31
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count2.05M
EPS (TTM)-8.73
FCF per share (TTM)-8.49

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-11.81M
Net income (TTM)-13.96M
EPS (TTM)-8.73
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.60M
Net receivables0.00
Total current assets2.63M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.63M
Accounts payable140.00K
Short/Current long term debt0.00
Total current liabilities973.00K
Total liabilities973.00K
Shareholder's equity1.65M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-10.59M
Capital expenditures (TTM)3.00M
Free cash flow (TTM)-13.59M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-845.16%
Return on Assets-531.89%
Return on Invested Capital-845.16%
Cash Return on Invested Capital-822.40%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.25
Daily high0.26
Daily low0.25
Daily Volume3K
All-time high13567.50
1y analyst estimate8.00
Beta-0.18
EPS (TTM)-8.73
Dividend per share-
Ex-div date-
Next earnings date13 May 2025

Downside potential

Loading...
Downside potential data
ATXIS&P500
Current price drop from All-time high-100.00%-14.41%
Highest price drop-100.00%-56.47%
Date of highest drop10 Apr 20259 Mar 2009
Avg drop from high-66.35%-11.07%
Avg time to new high123 days12 days
Max time to new high1150 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ATXI (Avenue Therapeutics Inc) company logo
Marketcap
513.68K
Marketcap category
Small-cap
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Employees
3
Investor relations
-
SEC filings
CEO
Lucy Lu
Country
USA
City
New York
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...